Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pulmonx (LUNG) EBT Margin (2019 - 2025)

Historic EBT Margin for Pulmonx (LUNG) over the last 7 years, with Q3 2025 value amounting to 64.31%.

  • Pulmonx's EBT Margin rose 41200.0% to 64.31% in Q3 2025 from the same period last year, while for Sep 2025 it was 61.39%, marking a year-over-year increase of 97200.0%. This contributed to the annual value of 66.71% for FY2024, which is 210600.0% up from last year.
  • As of Q3 2025, Pulmonx's EBT Margin stood at 64.31%, which was up 41200.0% from 62.85% recorded in Q2 2025.
  • Pulmonx's EBT Margin's 5-year high stood at 55.28% during Q4 2024, with a 5-year trough of 146.14% in Q1 2022.
  • Over the past 5 years, Pulmonx's median EBT Margin value was 84.0% (recorded in 2023), while the average stood at 88.06%.
  • The largest annual percentage gain for Pulmonx's EBT Margin in the last 5 years was 2172000bps (2021), contrasted with its biggest fall of -525200bps (2021).
  • Over the past 5 years, Pulmonx's EBT Margin (Quarter) stood at 93.77% in 2021, then rose by 3bps to 91.0% in 2022, then rose by 22bps to 70.75% in 2023, then grew by 22bps to 55.28% in 2024, then decreased by -16bps to 64.31% in 2025.
  • Its EBT Margin was 64.31% in Q3 2025, compared to 62.85% in Q2 2025 and 63.51% in Q1 2025.